Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage

Neuroscience Research

Volumn 74, Issue 3-4, 2012, Pages 290-297

  Sun, Chengming ^a   Meng, Qian ^a   Zhang, Lang ^a   Wang, Haitao ^a   Quirion, Remi ^b   Zheng, Wenhua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Brain ischemia; Glutamate; IGF 1; NMDA receptor; Tyrosine phosphorylation

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; GLUTAMIC ACID; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84871929557     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.10.001     Document Type: Article

References (45)

1. Adams H.P., del Zoppo G., Alberts M.J., Bhatt D.L., Brass L., Furlan A., Grubb R.L., Higashida R.T., Jauch E.C., Kidwell C., Lyden P.D., Morgenstern L.B., Qureshi A.I., Rosenwasser R.H., Scott P.A., Wijdicks E.F. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council. Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655-1711.
2. Adams T.E., Epa V.C., Garrett T.P., Ward C.W. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 2000, 57:1050-1093.
3. Beal M.F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 1992, 6:3338-3344.
4. Bergstedt K., Wieloch T. Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat. Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1. J. Cereb. Blood Flow Metab. 1993, 13:895-898.
5. Bondy C., Werner H., Roberts C.T., LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 1992, 46:909-923.
6. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 2003, 9:1180-1186.
7. Bui N.T., Konig H.G., Culmsee C., Bauerbach E., Poppe M., Krieglstein J., Prehn J.H. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones. J. Neurochem. 2002, 81:594-605.
8. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1998, 121:19-26.
9. Castaneda D., Zhao H., Mochly-Rosen D., Steinberg G.K. Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats. Brain Res. 2009, 1251:256-261.
10. Chang H.C., Yang Y.R., Wang P.S., Kuo C.H., Wang R.Y. Insulin-like growth factor I signaling for brain recovery and exercise ability in brain ischemic rats. Med. Sci. Sports Exerc. 2011, 43:2274-2280.
11. Ciani E., Virgili M., Contestabile A. Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurones. J. Neurochem. 2002, 81:218-228.
12. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 275:661-665.
13. Feldman E.L., Sullivan K.A., Kim B., Russell J.W. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis. 1997, 4:201-214.
14. Fletcher L., Kohli S., Sprague S.M., Scranton R.A., Lipton S.A., Parra A., Jimenez D.F., Digicaylioglu M. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J. Neurosurg. 2009, 111:164-170.
15. Garcia-Galloway E., Arango C., Pons S., Torres-Aleman I. Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol. Cell. Neurosci. 2003, 24:1027-1037.
16. Globus M.Y., Busto R., Martinez E., Valdes I., Dietrich W.D. Ischemia induces release of glutamate in regions spared from histopathologic damage in the rat. Stroke 1990, 21:III43-III46.
17. Ha S.K., Lee P., Park J.A., Oh H.R., Lee S.Y., Park J.H., Lee E.H., Ryu J.H., Lee K.R., Kim S.Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int. 2008, 52:878-886.
18. Haddad J.J. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?. Prog. Neurobiol. 2005, 77:252-282.
19. Ikonomidou C., Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol. 2002, 1:383-386.
20. Jiang Q., Gu Z., Zhang G., Jing G. Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons. Brain Res. 2000, 857:71-77.
21. Kilic E., Kilic U., Soliz J., Bassetti C.L., Gassmann M., Hermann D.M. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 2005, 19:2026-2028.
22. Kooijman R., Sarre S., Michotte Y., De Keyser J. Insulin-like growth factor I: a potential neuroprotective compound for the treatment of acute ischemic stroke?. Stroke 2009, 40:e83-e88.
23. Kristiansen L.V., Huerta I., Beneyto M., Meador-Woodruff J.H. NMDA receptors and schizophrenia. Curr. Opin. Pharmacol. 2007, 7:48-55.
24. Kumari S., Liu X., Nguyen T., Zhang X., D'Mello S.R. Distinct phosphorylation patterns underlie Akt activation by different survival factors in neurons. Brain Res. Mol. Brain Res. 2001, 96:157-162.
25. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16:143-163.
26. Liu X.F., Fawcett J.R., Thorne R.G., DeFor T.A., Frey W.H. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J. Neurol. Sci. 2001, 187:91-97.
27. Mackay K.B., Loddick S.A., Naeve G.S., Vana A.M., Verge G.M., Foster A.C. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo. J. Cereb. Blood Flow Metab. 2003, 23:1160-1167.
28. Mattson M.P. Calcium and neurodegeneration. Aging Cell 2007, 6:337-350.
29. Noshita N., Lewen A., Sugawara T., Chan P.H. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2001, 21:1442-1450.
30. Pellegrini-Giampietro D.E., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 1990, 10:1035-1041.
31. Quesada A., Lee B.Y., Micevych P.E. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev. Neurobiol. 2008, 68:632-644.
32. Roettger V., Lipton P. Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience 1996, 75:677-685.
33. Rusanescu G., Yang W., Bai A., Neel B.G., Feig L.A. Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicity. EMBO J. 2005, 24:305-314.
34. Sawe N., Steinberg G., Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J. Neurosci. Res. 2008, 86:1659-1669.
35. Selvamani A., Sohrabji F. The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J. Neurosci. 2010, 30:6852-6861.
36. Vincent A.M., Feldman E.L., Song D.K., Jung V., Schild A., Zhang W., Imperiale M.J., Boulis N.M. Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro. Neuromolecular Med. 2004, 6:79-85.
37. Vincent A.M., Mobley B.C., Hiller A., Feldman E.L. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol. Dis. 2004, 16:407-416.
38. Walsh P.T., Smith L.M., O'Connor R. Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes. Immunology 2002, 107:461-471.
39. Wang J.M., Hayashi T., Zhang W.R., Sakai K., Shiro Y., Abe K. Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats. Brain Res. 2000, 859:381-385.
40. Zhao H., Sapolsky R.M., Steinberg G.K. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 2006, 34:249-270.
41. Zhao H., Shimohata T., Wang J.Q., Sun G., Schaal D.W., Sapolsky R.M., Steinberg G.K. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J. Neurosci. 2005, 25:9794-9806.
42. Zheng W.H., Kar S., Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J. Neurochem. 2002, 80:1049-1061.
43. Zheng W.H., Kar S., Quirion R. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol. Pharmacol. 2002, 62:225-233.
44. Zheng W.H., Quirion R. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J. Neurochem. 2004, 89:844-852.
45. Zheng W.H., Quirion R. Glutamate acting on N-methyl-d-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J. Biol. Chem. 2009, 284:855-861.